Back to Authors

Godwin, John E.

https://orcid.org/0000-0003-3876-2505

A5054425800 | I2801670537

Mayo Clinic

16Providence, Portland, United States

Citations 11

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Blood Advances | July 20, 2018 | Volume: 2 | Issue: 14 | Pages: 1705-1718

10.1182/bloodadvances.2017015396 | PMID 30030269

Key PointsBrief lenalidomide consolidation after chemoimmunotherapy is acceptably tolerated and extends PFS and OS in CLL. FCR has superior efficacy compared with FR chemoimmunotherapy for CLL.